Lisata Therapeutics (LSTA) Invested Capital (2016 - 2025)
Historic Invested Capital for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $17.4 million.
- Lisata Therapeutics' Invested Capital fell 4843.28% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year decrease of 4843.28%. This contributed to the annual value of $29.6 million for FY2024, which is 3858.31% down from last year.
- According to the latest figures from Q3 2025, Lisata Therapeutics' Invested Capital is $17.4 million, which was down 4843.28% from $21.0 million recorded in Q2 2025.
- Over the past 5 years, Lisata Therapeutics' Invested Capital peaked at $61.0 million during Q1 2023, and registered a low of $17.4 million during Q3 2025.
- In the last 3 years, Lisata Therapeutics' Invested Capital had a median value of $38.2 million in 2024 and averaged $38.9 million.
- In the last 5 years, Lisata Therapeutics' Invested Capital plummeted by 2946.34% in 2024 and then tumbled by 4843.28% in 2025.
- Quarter analysis of 3 years shows Lisata Therapeutics' Invested Capital stood at $48.1 million in 2023, then tumbled by 38.58% to $29.6 million in 2024, then tumbled by 41.25% to $17.4 million in 2025.
- Its Invested Capital was $17.4 million in Q3 2025, compared to $21.0 million in Q2 2025 and $25.4 million in Q1 2025.